At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 84 enrolled
Drug / intervention
Liposomal Bupivacaine with Bupivacainedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Impact of Liposomal Bupivicaine on Post-Operative Pain in Orthopaedic Trauma Surgery: A Double-Blind Prospective Randomized Control Trial
In Brief
A Phase 3 clinical trial evaluating Liposomal Bupivacaine with Bupivacaine for Ankle Fracture. Completed, enrolled 84 participants across 1 site.
Detailed Summary
This study is a randomized controlled trial assessing pain control in ankle fractures repaired with open reduction and internal fixation. Patients are consented and enrolled pre-operatively, and randomized to either control or liposomal bupivacaine with bupivacaine administered intra-operatively.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnkle Fracture
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartDec 2014
First PostedJun 2015
Primary CompletionJun 2016
Study CompletionAug 2016
TodayJul 2026
First PostedJun 24, 2015
Enrollment StartDec 1, 2014
Primary CompletionJun 30, 2016
Study CompletionAug 31, 2016
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 11.0 years ago
Interventions
Liposomal Bupivacaine with Bupivacainedrug
Pain medications injected locally during surgery around affected ankle.